|
| Number | Title | IPC | Assignee | Publication date
(MM/DD/YYYY) |
|
| 1 | Use of DKK-1 protein in the cancer diagnosis | A61B 5/00 (20060101);
A61B 8/00 (20060101);
A61B 10/00 (20060101) | Shanghai Cancer Institute
(Shenzhen, CN) | 12/27/2012 |
|
| 2 | Monoclonal antibodies binding to avian influenza virus subtype H5 hemagglutinin and uses thereof | A61K 39/42 (20060101) | Xiamen University
(Fujian Province, CN) | 12/22/2011 |
|
| 3 | Fully human anti-TNF-alpha monoclonal antibody, preparation method, and use thereof | A61K 39/395 (20060101);
C07K 16/24 (20060101);
C12N 5/10 (20060101);
C12N 15/13 (20060101);
C12N 15/00 (20060101) | Shanghai Biomabs Pharmaceuticals Co., Ltd. (Shanghai, CN) | 12/06/2012 |
|
| 4 | Anti-EFGRv3 monoclonal antibody | A61K 39/395 (20060101);
C12P 19/34 (20060101) | Shanghai Cancer Institute
(Shanghai, CN) | 02/14/2013 |
|
| 5 | Use of DKK-1 protein in the cancer diagnosis | A61K 51/00 (20060101);
A61M 36/14 (20060101) | Shanghai Cancer Institute
(Shanghai, CN) | 05/14/2009 |
|
| 6 | Anti-VEGFR monoclonal antibody, method of making, and uses thereof | A61K 39/395 (20060101);
C07K 16/00 (20060101);
A61K 39/00 (20060101);
C07K 16/28 (20060101) | Shanghai Aosaiersi Biotech Co., Ltd.
(Shanghai, CN) | 02/17/2011 |
|
| 7 | Anti-human trail receptor DR5 monoclonal antibody (AD5-10), method thereof, and use of the same | C12P 21/08 (20060101);
C12N 5/16 (20100101);
C12N 5/07 (20100101); A61K39/395 (20060101);
C07K 16/00 (20060101) | The Institute of Basic Medical Sciences of Chinese Academy of Medical Sciences
(Beijing, CN) | 04/01/2010 |
|
| 8 | Monoclonal antibody against hepatitis E virus or its fragment with binding activity and use thereof | C12P 21/08 (20060101);
C07K 16/00 (20060101) | Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (Haikou, CN) | 10/19/2006 |
|
| 9 | Method and composition for diagnosis of melanocytic lesions | G01N 33/53 (20060101); G01N 33/574 (20060101) | Shanghai CP GuoJian Pharmaceutical Co., Ltd.
(Shanghai, CN) | N/A |
|
